Regeneron Secures $256 Million to Power Life-Transforming Innovations in Biopharma

We're thrilled to announce that Regeneron has successfully raised $256,000,000 in new funding—a significant milestone that underscores our commitment to revolutionizing the future of healthcare. At Regeneron, we believe that when the right idea finds the right team, powerful change is possible. This recent investment will accelerate our mission to invent, develop, and commercialize life-transforming medicines for people suffering from serious diseases. With this funding, we plan to bolster our expanding global network by enhancing our research processes, advancing scientific innovation, and optimizing our state-of-the-art manufacturing facilities. We are committed to developing cutting-edge therapies and redefining what it means to care for health, all while setting new benchmarks in how science and commercialization intersect. This infusion of capital is not only a vote of confidence in our vision and our dedicated teams across the globe, but it also positions us to deepen our exploration into novel treatments that address unmet medical needs. By strengthening our resources and capabilities, we are poised to make an even greater impact in the lives of patients and healthcare communities around the world. We invite you to learn more about our journey and join us as we continue to build a future we believe in. For additional insights on our approach and how you can connect with us, please visit www.regeneron.com/social-media-terms. Rest assured, as we advance our mission, Regeneron remains steadfast in its commitment to privacy and security, and we will never request sensitive personal information via email or social media.